S Tiberi Selected Research

S Tiberi Research Topics

4	Infections 07/2022 - 01/2018
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2019 - 08/2016
3	Tuberculosis (Tuberculoses) 07/2022 - 03/2021
2	Extensively Drug-Resistant Tuberculosis 01/2021 - 12/2015
1	Pulmonary Tuberculosis 07/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	COVID-19 03/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2018

4	Pharmaceutical PreparationsIBA 01/2022 - 12/2015
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	Biological ProductsIBA 03/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Rifabutin (Ansamycin)FDA Link 12/2017
1	bedaquiline (R207910)IBA 08/2016
1	Ethionamide (Trecator-SC)FDA Link 12/2015
1	FluoroquinolonesIBA 12/2015
1	Ethambutol (Myambutol)FDA LinkGeneric 12/2015
1	Prothionamide (Protionamide)IBA 12/2015
1	Pyrazinamide FDA LinkGeneric 12/2015

2	Therapeutics 01/2022 - 08/2016
1	Critical Care (Surgical Intensive Care) 07/2022
1	Artificial Respiration (Mechanical Ventilation) 07/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2018
1	Injections 12/2015